Neutropenia Febril

Febrile Neutropenia

Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America. [Internet]. Clin Infect Dis. 2011;52:e56. Disponible en: https://doi.org/10.1093/cid/cir073

Schimpff S, Satterlee W, Young VM, Serpick A. Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia. [Internet]. N Engl J Med. 1971;284:1061. Disponible en: https://doi.org/10.1056/NEJM197105132841904

Talcott JA, Siegel RD, Finberg R, Goldman L. Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule. [Internet]. JClinOncol. 1992;10:316. Disponible en: https://doi.org/10.1200/JCO.1992.10.2.316

Uys A, Rapoport BL, Anderson R. Febrile neutropenia: a prospective study to validate the Multinational Association of Supportive Care of Cancer (MASCC) risk-index score. [Internet]. Support Care Cancer. 2004;12:555. Disponible en: https://doi.org/10.1007/s00520-004-0614-5

Carmona-Bayonas A, Jiménez-Fonseca P, Virizuela Echaburu J, et al. Prediction of serious complications in patients with seemingly stable febrile neutropenia: validation of the Clinical Index of Stable Febrile Neutropenia in a prospective cohort of patients from the FINITE study. [Internet]. J Clin Oncol. 2015;33:465. Disponible en: https://doi.org/10.1200/JCO.2014.57.2347

Ramos P, Sánchez R, Gamboa Ó, Cardona AF. Factores pronósticos relacionados con la mortalidad en pacientes con cáncer y neutropenia febril. [Internet]. RevColHematolOncol 2012;1(4):15–22. Disponible en: https://doi.org/10.51643/RevColHemOnc